Abstract
Acute hypoxia in the lung causes arteriolar vasoconstriction whereas prolonged hypoxia promotes proliferation and migration of vascular smooth muscle cells (VSMC) and extracellular matrix deposition in the arterial wall, a process known as vascular remodeling.1 These abnormalities are characteristic of pulmonary hypertension.2 Several clinical conditions characterized by lung inflammation have been linked to the development of chronic pulmonary hypertension.3 Interestingly, perivascular inflammatory cell infiltration as well as increased serum levels of pro-inflammatory cytokines, such as interleukin (IL)-lβ and IL-6, have been reported in clinical cases of primary pulmonary hypertension.4-5 However, little attention has been given up to now to the role of pulmonary inflammation in the pathogenesis of pulmonary hypertension induced by hypoxia.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
S. Kourembanas, T. Morita, Y. Liu, and H. Christou, Mechanisms by which oxygen regulates gene expression and cell-cell interaction in the vasculature, Kidney Intern. 51, 438–443 (1997).
R.P. Mecham, L.A. Whitehouse, D.S. Wrenn, W.C. Parks, G.L. Griffin, R.M. Senior, E.C. Crouch, K.R. Stenmark, and N.F. Voelkel, Smooth muscle-mediated connective tissue remodeling in pulmonary hypertension, Science. 237, 423–426 (1987).
W.M. Zapol and M.T. Snider, Pulmonary hypertension in severe acute respiratory failure, N. Engl. J. Med. 3, 476–480 (1977).
R.M. Tuder, B. Groves, D.B. Badesch, and N.F. Voelkel, Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension, Am. J. Pathol. 144, 275–285 (1994).
M. Humbert, G. Monti, F. Brenot, O. Sitbon, A. Portier, L. Grangeot-Keros, P. Duroux, P. Galanaud, G. Simonneau, and D. Emilie, Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension, Am. J. Respir. Crit. Care Med. 151, 1628–1631 (1995).
N.G. Abraham, G.S. Drummond, J.D. Lutton and A. Kappas, The biological significance and physiological role of heme oxygenase, Cell. Physiol. Biochem. 6, 129–168 (1996).
W.K. McCoubrey, T.J. Huang, and M.D. Maines, Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3, Eur. J. Biochem. 247, 725–732 (1997).
T. Morita, M.A. Perrella, M.-E. Lee, and S. Kourembanas, Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP, Proc. Natl. Acad. Sci. USA. 92, 1475–1479 (1995).
T. Morita and S. Kourembanas, Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide, J. Clin. Invest. 96, 2676–2682 (1995).
T. Morita, S.A. Mitsialis, H. Koike, Y. Liu, and S. Kourembanas, Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells, J. Biol. Chem. 272, 32804–32809 (1997).
M.P. Soares, Y. Lin, J. Anrather, E. Csizmadia, K. Takigami, K. Sato, S.T. Grey, R.B. Colvin, A.M. Choi, K.D. Poss, and F.H. Bach, Expression of heme oxygenase-1 can determine cardiac xenograft survival, Nature Med. 4, 1073–1077 (1998).
S.-F. Yet, M.A. Perrella, M.D. Layne, C.-M. Hsieh, K. Maemura, L. Kobzik, P. Wiesel, H. Christou, S. Kourembanas, and M.-E. Lee, Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice, J. Clin. Invest. 103, R23–R29 (1999).
T.R. Korfhagen, S.W. Glasser, S.E. Wert, M.D. Bruno, C.C. Daugherty, J.D. McNeish, J.L. Stock, S.S. Potter, and J.A. Whitsett, Cis-acting sequences from a human surfactant protein gene confer pulmonary-specific gene expression in transgenic mice, Proc. Natl. Acad. Sci. USA. 87, 6122–6126 (1990).
S.W. Glasser, T.R. Korfhagen, S.E. Wert, M.D. Bruno, K.M. McWilliams, D.K. Vorbroker, and J.A. Whitsett, Genetic element from human surfactant protein SP-C gene confers bronchiolar-alveolar cell specificity in transgenic mice, Am. Phys. Soc. ··, L349-L356 (1991).
A. Xing, M. Jordana, J. Gauldie, and J. Wang, Cytokines and pulmonary inflammatory and immune diseases, Histol. Histopathol. 14, 185–201 (1999).
M. Roth, M. Nauck, M. Tamm, A.P. Perruchoud, R. Ziesche, and L.H. Blck, Intracellular interleukin 6 mediates platelet-derived growth factor-induced proliferation of nontransformed cells, Proc. Natl. Acad. Sci. USA. 92, 1312–1316 (1995).
T.L. Yue, X. Wang, C.P Sung, B. Olson, P.J. McKenna, J.L. Gu, and G.Z. Feuerstein, Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells, Circ. Res. 75, 1–7 (1994).
C.A. Lawson, S.D. Yan, S.F. Yan, H. Liao, Y.S. Zhou, J. Sobel, W. Kisiel, D.M. Stern, and D.J. Pinsky, Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation, J. Clin. Invest. 99, 1729–1738 (1997).
R.M. Strieter, S.L. Kunkel, M.P Keane, and T.J. Standford, Chemokines in lung injury, Chest. 116, 103S–110S (1999).
M.H. Ali, S.A. Schlidt, N.S. Chandel, K.L. Hynes, P.T. Schumacker, and B.L. Gewertz, Endothelial permeability and IL-6 production during hypoxia: role of ROS in signal transduction, Am. J. Physiol. 277, L1057–L1065 (1999).
A.D. Schecter, B.J. Rollins, Y.J. Zhang, I.F. Charo, J.T. Fallon, M. Rossikhina, P.L.A. Giesen, Y. Nemerson, and M.B. Taubman, Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells, J. Biol. Chem. 272, 28568–28573 (1997).
L. Boring, J. Gosling, M. Cleary, and I.F. Charo, Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis, Nature. 394, 894–897 (1998).
N.F. Voelkel, R.M. Tuder, J. Bridges, and W.P. Arend, Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline, Am J Respir Cell Mol Biol. 11, 664–675 (1994).
H. Kimura, Y. Kasahara, K. Kurosu, K. Sugito, Y. Takiguchi, M. Terai, A. Mikata, M. Natsume, N. Mukaida, K. Matsushima, and T. Kuriyama, Alleviation of monocrotaline-induced pulmonary hypertension by antibodies to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1, Lab. Invest. 78, 571–581 (1998).
K. Thompson and M. Rabinovitch, Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular matrix-bound basic fibroblast growth factor, J. Cell. Physiol. 166, 495–505 (1996).
K. Maruyama, C. Ye, M. Woo, H. Venkatacharya, L.D. Lines, M.M. Silver, and M. Rabinovitch, Chronic hypoxic pulmonary hypertension in rats and increased elastolytic activity, Am. J. Physiol. 261, H1716–H1726 (1991).
PL. Jones, K.N. Cowan, and M. Rabinovitch, Tenascin-C, proliferation and subendothelial accumulation of fibronectin in progressive pulmonary vascular disease, Am. J. Pathol. 150, 1349–1360 (1997).
K.N. Cowan, A. Heilbut, T. Humpl, C. Lam, S. Ito, and M. Rabinovitch, Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor, Nat. Med. 6, 698–702 (2000).
N.S. Chandel, E. Maltepe, E. Goldwasser, C.E. Mathieu, M.C. Simon, and P.T. Schumacker, Mitochondrial reactive oxygen species trigger hypoxia-induced transcription, Proc. Natl. Acad. Sci. USA. 95, 11715–11720(1998).
L.E. Otterbein, F.H. Bach, J. Alam, M. Soares, H.T. Lu, M. Wysk, R.J. Davis, R.A. Flavell, and A.M.K. Choi, Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway, Nat. Med. 6, 422–428 (2000).
L.E. Otterbein, J.K. Kolls, L.L. Mantell, J.L. Cook, J. Alam, and A.M.K. Choi, Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury, J. Clin. Invest. 103, 1047–1054 (1999).
F. Amersi, R. Beulow, H. Kato, B. Ke, A.J. Coito, X.-D. Shen, D. Zhao, J. Zaky, J. Melinek, C.R. Lassman, J.K. Kolls, J. Alam, T. Ritter, H.-D. Volk, D.G. Farmer, R.M. Ghobrial, R.W. Busuttil, and J.W. Kupiec-Weglinski, Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury, J. Clin. Invest. 104, 1631–1639 (1999).
Z. Xing, J. Gauldie, G. Cox, H. Baumann, M. Jordana, Z.-F. Lei, and M.K. Achong, IL-6 an anti- inflammatory cytokine required for controlling local or systemic acute inflammatory responses, J. Clin. Invest. 101, 311–320 (1998).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kourembanas, S. et al. (2002). Targeted Expression of Heme Oxygenase-1 and Pulmonary Responses to Hypoxia. In: Abraham, N.G. (eds) Heme Oxygenase in Biology and Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0741-3_16
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0741-3_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5219-8
Online ISBN: 978-1-4615-0741-3
eBook Packages: Springer Book Archive